Consensus statement: oral complications of cancer therapies. National Institutes of Health Consensus Development Panel.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009059:Mouth Diseases / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy; D009369:Neoplasms / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects*; D014481:United States
D000970:Antineoplastic Agents